Conformation Sensors that Distinguish Monomeric Proteins from Oligomers in Live Cells

Chemistry and Biology

Volumn 17, Issue 4, 2010, Pages 371-379

  Ramdzan, Yasmin M ^a   Nisbet, Rebecca M ^a   Miller, Jason ^b,c   Finkbeiner, Steven ^b,c,d   Hill, Andrew F ^a   Hatters, Danny M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CELLBIO; CHEMBIO

Indexed keywords

NERVE PROTEIN;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; GENETICS; HUMAN; HUNTINGTON CHOREA; METABOLISM; MUTATION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION;

ANIMALS; CELL LINE; HUMANS; HUNTINGTON DISEASE; MUTATION; NERVE TISSUE PROTEINS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION;

EID: 77950932967     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2010.03.011     Document Type: Article

References (39)

1. Adams S.R., Campbell R.E., Gross L.A., Martin B.R., Walkup G.K., Yao Y., Llopis J., and Tsien R.Y. New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J. Am. Chem. Soc. 124 (2002) 6063-6076
2. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
3. Atwal R.S., Xia J., Pinchev D., Taylor J., Epand R.M., and Truant R. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum. Mol. Genet. 16 (2007) 2600-2615
4. Bennett E.J., Shaler T.A., Woodman B., Ryu K.-Y., Zaitseva T.S., Becker C.H., Bates G.P., Schulman H., and Kopito R.R. Global changes to the ubiquitin system in Huntington's disease. Nature 448 (2007) 704-708
5. Bennett M.J., Huey-Tubman K.E., Herr A.B., West Jr. A.P., Ross S.A., and Bjorkman P.J. A linear lattice model for polyglutamine in CAG-expansion diseases. Proc. Natl. Acad. Sci. USA 99 (2002) 11634-11639
6. Berger Z., Davies J.E., Luo S., Pasco M.Y., Majoul I., O'Kane C.J., and Rubinsztein D.C. Deleterious and protective properties of an aggregate-prone protein with a polyalanine expansion. Hum. Mol. Genet. 15 (2006) 453-465
7. Brignull H.R., Morley J.F., Garcia S.M., Morimoto R.I., Kheterpal I., and Wetzel R. Modeling polyglutamine pathogenesis in C. elegans. Methods Enzymol. 412 (2006) 256
8. Chen S., Berthelier V., Yang W., and Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 311 (2001) 173-182
9. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
10. Coleman B.M., Nisbet R.M., Han S., Cappai R., Hatters D.M., and Hill A.F. Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence. Biochem. Biophys. Res. Commun. 380 (2009) 564-568
11. Crick S.L., Jayaraman M., Frieden C., Wetzel R., and Pappu R.V. Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions. Proc. Natl. Acad. Sci. USA 103 (2006) 16764-16769
12. Dougan L., Li J., Badilla C.L., Berne B.J., and Fernandez J.M. Single homopolypeptide chains collapse into mechanically rigid conformations. Proc. Natl. Acad. Sci. USA 106 (2009) 12605-12610
13. Duennwald M.L., Jagadish S., Muchowski P.J., and Lindquist S. Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc. Natl. Acad. Sci. USA 103 (2006) 11045-11050
14. Haass C., and Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 8 (2007) 101-112
15. Hatters D.M. Protein misfolding inside cells: the case of huntingtin and Huntington's disease. IUBMB Life 60 (2008) 724-728
16. Ignatova Z., and Gierasch L.M. Monitoring protein stability and aggregation in vivo by real-time fluorescent labeling. Proc. Natl. Acad. Sci. USA 101 (2004) 523-528
17. Jackson G.R., Salecker I., Dong X., Yao X., Arnheim N., Faber P.W., MacDonald M.E., and Zipursky S.L. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21 (1998) 633
18. Kaganovich D., Kopito R., and Frydman J. Misfolded proteins partition between two distinct quality control compartments. Nature 454 (2008) 1088-1095
19. Kim S., Nollen E.A.A., Kitagawa K., Bindokas V.P., and Morimoto R.I. Polyglutamine protein aggregates are dynamic. Nat. Cell Biol. 4 (2002) 826-831
20. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10 (2000) 524
21. Luedtke N.W., Dexter R.J., Fried D.B., and Schepartz A. Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH. Nat. Chem. Biol. 3 (2007) 779-784
22. MacDonald M.E., Ambrose C.M., Duyao M.P., Myers R.H., Lin C., Srinidhi L., Barnes G., Taylor S.A., James M., Groot N., et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
23. Madani F., Lind J., Damberg P., Adams S.R., Tsien R.Y., and Gräslund A.O. Hairpin structure of a biarsenical-tetracysteine motif determined by NMR spectroscopy. J. Am. Chem. Soc. 131 (2009) 4613-4615
24. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., and Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 (1996) 493-506
25. Matsumoto G., Kim S., and Morimoto R.I. Huntingtin and mutant SOD1 form aggregate structures with distinct molecular properties in human cells. J. Biol. Chem. 281 (2006) 4477-4485
26. Nagai Y., Inui T., Popiel H.A., Fujikake N., Hasegawa K., Urade Y., Goto Y., Naiki H., and Toda T. A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol. 14 (2007) 332-340
27. Perutz M.F., Johnson T., Suzuki M., and Finch J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91 (1994) 5355-5358
28. Rizzo M.A., Springer G.H., Granada B., and Piston D.W. An improved cyan fluorescent protein variant useful for FRET. Nat. Biotechnol. 22 (2004) 445-449
29. Roberti M.J., Bertoncini C.W., Klement R., Jares-Erijman E.A., and Jovin T.M. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged α-synuclein. Nat. Methods 4 (2007) 345-351
30. Rockabrand E., Slepko N., Pantalone A., Nukala V.N., Kazantsev A., Marsh J.L., Sullivan P.G., Steffan J.S., Sensi S.L., and Thompson L.M. The first 17 amino acids of huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum. Mol. Genet. 16 (2007) 61-77
31. Schaffar G., Breuer P., Boteva R., Behrends C., Tzvetkov N., Strippel N., Sakahira H., Siegers K., Hayer-Hartl M., and Hartl F.U. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell 15 (2004) 95-105
32. Scherzinger E., Sittler A., Schweiger K., Heiser V., Lurz R., Hasenbank R., Bates G.P., Lehrach H., and Wanker E.E. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. USA 96 (1999) 4604-4609
33. Steffan J.S., Agrawal N., Pallos J., Rockabrand E., Trotman L.C., Slepko N., Illes K., Lukacsovich T., Zhu Y.-Z., Cattaneo E., et al. SUMO modification of huntingtin and Huntington's disease pathology. Science 304 (2004) 100-104
34. Takahashi T., Kikuchi S., Katada S., Nagai Y., Nishizawa M., and Onodera O. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum. Mol. Genet. 17 (2008) 345-356
35. Thakur A.K., and Wetzel R. Mutational analysis of the structural organization of polyglutamine aggregates. Proc. Natl. Acad. Sci. USA 99 (2002) 17014-17019
36. Thakur A.K., Jayaraman M., Mishra R., Thakur M., Chellgren V.M., Byeon I.-J., Anjum D.H., Kodali R., Creamer T.P., Conway J.F., Gronenborn A.M., and Wetzel R. Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol. 16 (2009) 380-389
37. Wang Y., Meriin A.B., Zaarur N., Romanova N.V., Chernoff Y.O., Costello C.E., and Sherman M.Y. Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J. 23 (2009) 451-463
38. Zoghbi H.Y., and Orr H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23 (2000) 217-247
39. N repeat in the Huntington disease gene. Hum. Mol. Genet. 2 (1993) 2063-2067